Pulmonary metastasis vs. control group | Primary lung cancer vs. control group | |||||
Biomarker | Malignant (n = 146) | Benign (n = 29) | P | Malignant (n = 140) | Benign (n = 29) | P |
T/M ratio | 3.25 ± 0.22 | 2.12 ± 0.25 | 0.0261 | 5.96 ± 0.38 | 2.12 ± 0.25 | <0.0001 |
Glut1 | 2.92 ± 0.08 | 1.83 ± 0.16 | <0.0001 | 2.42 ± 0.09 | 1.83 ± 0.16 | 0.0048 |
Glut3 | 1.27 ± 0.05 | 1.76 ± 0.15 | 0.0003 | 1.30 ± 0.06 | 1.76 ± 0.15 | 0.0012 |
Hexokinase I | 2.53 ± 0.09 | 1.89 ± 0.15 | 0.0022 | 2.81 ± 0.10 | 1.89 ± 0.15 | <0.0001 |
HIF-1α | 2.90 ± 0.09 | 2.10 ± 0.17 | 0.0003 | 3.42 ± 0.11 | 2.10 ± 0.17 | <0.0001 |
VEGF | 23.9 ± 1.50 | 13.2 ± 2.34 | 0.0024 | 30.3 ± 1.70 | 13.2 ± 2.34 | <0.0001 |
CD34 | 25.1 ± 0.90 | 17.8 ± 1.73 | 0.0019 | 24.0 ± 1.10 | 17.8 ± 1.73 | 0.0125 |